HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
1.990
+0.040 (2.05%)
At close: May 1, 2026, 4:00 PM EDT
2.000
+0.010 (0.50%)
After-hours: May 1, 2026, 7:20 PM EDT
HeartSciences Revenue
In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%.
Revenue (ttm)
$4.35K
Revenue Growth
-76.61%
P/S Ratio
731.38
Revenue / Employee
$578
Employees
15
Market Cap
6.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 4.35K | -14.25K | -76.61% |
| Apr 30, 2024 | 18.60K | 13.45K | 261.17% |
| Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
| Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
| Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
| Apr 30, 2020 | 64.18K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 17.44M |
| Beyond Air | 6.92M |
| Biomerica | 4.33M |
| Tenon Medical | 3.94M |
| Intelligent Bio Solutions | 3.58M |
| Sintx Technologies | 1.02M |
| Co-Diagnostics | 622.49K |
| iTonic Holdings | 523.03K |
HSCS News
- 18 days ago - HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - GlobeNewsWire
- 5 weeks ago - HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - GlobeNewsWire
- 5 weeks ago - HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings - GlobeNewsWire
- 6 weeks ago - HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - GlobeNewsWire
- 3 months ago - Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - GlobeNewsWire
- 4 months ago - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - GlobeNewsWire